Mendel DB, Laird AD, Xin X, Louie SG, Christensen JG, Li G, Schreck RE, Abrams TJ, Ngai TJ, Lee LB, Murray LJ, Carver J, Chan E, Moss KG, Haznedar JO, Sukbuntherng J, Blake RA, Sun L, Tang C, Miller T, Shirazian S, McMahon G, Cherrington JM: In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: Determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res. 2003, 9: 327-337.
CAS
PubMed
Google Scholar
Motzer R, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, Oudard S, Negrier S, Szczylik C, Kim ST, Chen I, Bycott PW, Baum CM, Figlin RA: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007, 356: 115-124. 10.1056/NEJMoa065044.
Article
CAS
PubMed
Google Scholar
Deprimo SE, Bello CL, Smeraglia J, Baum CM, Spinella D, Rini BI, Michaelson MD, Motzer RJ: Circulating protein biomarkers of pharmacodynamic activity of sunitinib, in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins. J Transl Med. 2007, 5: 32-10.1186/1479-5876-5-32.
Article
PubMed
PubMed Central
Google Scholar
DePrimo SE, Bello C: Surrogate biomarkers in evaluating response to anti-angiogenic agents: focus on sunitinib. Ann Oncol. 2007, 18 (Suppl 10): x11-9. 10.1093/annonc/mdm409.
Article
PubMed
Google Scholar
Chu TF, Rupnick MA, Kerkela R, Dallabrida SM, Zurakowski D, Nguyen L, Woulfe K, Pravda E, Cassiola F, Desai J, George S, Morgan JA, Harris DM, Ismail NS, Chen JH, Schoen FJ, Van den Abbeele AD, Demetri GD, Force T, Chen MH: Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet. 2007, 370: 2011-2019. 10.1016/S0140-6736(07)61865-0.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schmidinger M, Zielinski CC, Vogl UM, Bojic A, Bojic M, Schukro C, Ruhsam M, Hejna M, Schmidinger H: Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol. 2008, 26: 5204-5212. 10.1200/JCO.2007.15.6331.
Article
PubMed
Google Scholar
Rixe O, Billemont B, Izzedine H: Hypertension as a predictive factor of Sunitinib activity. Ann Oncol. 2007, 18: 1117-10.1093/annonc/mdm184.
Article
CAS
PubMed
Google Scholar
Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W: Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 2001, 38: 1934-1941. 10.1016/S0735-1097(01)01672-2.
Article
CAS
PubMed
Google Scholar
Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN, Val-HeFT Investigators: Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2003, 107: 1278-1283. 10.1161/01.CIR.0000054164.99881.00.
Article
CAS
PubMed
Google Scholar
Kontovinis LF, Papazisis KT, Touplikioti P, Andreadis C, Mouratidou D, Kortsaris AH: Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers. BMC Cancer. 2009, 9: 82-10.1186/1471-2407-9-82.
Article
PubMed
PubMed Central
Google Scholar
Contal C, O'Quigley J: An application of changepoint methods in studying the effect of age on survival in breast cancer. Computational Statistics and Data Analysis. 1999, 30: 253-270. 10.1016/S0167-9473(98)00096-6.
Article
Google Scholar
Wang TJ, Larson MG, Levy D, Leip EP, Benjamin EJ, Wilson PW, Sutherland P, Omland T, Vasan RS: Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol. 2002, 90: 254-8. 10.1016/S0002-9149(02)02464-5.
Article
CAS
PubMed
Google Scholar
Gerbes AL, Dagnino L, Nguyen T, Nemer M: Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues. J Clin Endocrinol Metab. 1994, 78: 1307-1311. 10.1210/jc.78.6.1307.
CAS
PubMed
Google Scholar
Weidemann A, Klanke B, Wagner M, Volk T, Willam C, Wiesener MS, Eckardt KU, Warnecke C: Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J. 2008, 409 (1): 233-42. 10.1042/BJ20070629.
Article
CAS
PubMed
Google Scholar
Czabanka M, Vinci M, Heppner F, Ullrich A, Vajkoczy P: Effects of sunitinib on tumor hemodynamics and delivery chemotherapy. Int J Cancer. 2009, 124 (6): 1293-300. 10.1002/ijc.24019.
Article
CAS
PubMed
Google Scholar
Hilman GG, Singh-Gupta V, Zhang H, Al-Bashir AK, Katkuri Y, Li M, Yunker CK, Patel AD, Abrams J, Haacke EM: Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors. Neoplasia. 2009, 11 (9): 910-20.
Article
Google Scholar